NEW IMPACT FACTOR JUST ANNOUNCED - 3.503

British Journal of Dermatology

An Official Journal of the British Association of Dermatologists

Edited by:
Dr John English, Nottingham, UK

ISI Journal Citation Reports® Ranking: 2007: 3/41 (Dermatology)
Impact Factor: 3.503

---

Publishing a unique balance of basic science and clinical research

First choice in dermatology

• One of the top dermatology journals in the world - latest Impact Factor is 3.503
• High quality original research of instant importance - Immediacy Index 0.483

Speed of Publication

• 70 days from receipt at publisher to print publication
• Articles published online weeks ahead of print publication
• Best author services - includes better paper tracking through production, no color charges and discounts on Wiley-Blackwell publications

International Readership

• Available in more than 5,000 medical and scientific libraries worldwide
• Free e- alerts or RSS feeds for all registered users
• Funded Access - articles immediately available online, free for all upon payment of a one time author fee

Join the ranks of the best authors in the world and submit your next paper to BJD

The British Journal of Dermatology publishes papers on all aspects of the biology and pathology of the skin. Originally the Journal, founded in 1888, was devoted almost exclusively to the interests of the dermatologist in clinical practice. However, the rapid development, since the 1950s, of research on the physiology and experimental pathology of the skin has been reflected in the contents of the Journal, which now provides a vehicle for the publication of both experimental and clinical ethical research and serves equally the laboratory worker and the clinician.

TopNews and Announcements

Online content now available back to Volume 29 (1917)
Back issues of this journal are now available online. For further information on how to access these issues please visit our Librarian Site.

Free access in the developing world
Free online access to this journal is available within institutions in the developing world through
the HINARI initiative with the World Health Organization (WHO).

Articles published online ahead of print
Articles which have been fully copy-edited and peer-reviewed are published online through our Early View feature
before the print edition of this journal is published.

NIH Public Access Mandate
For those interested in the Wiley-Blackwell policy on the NIH Public Access Mandate,  please visit our policy statement. 

 

TopHighlights

Limited free access to a selection of the top-cited articles from volumes 154/155 (2006)

A population-based study of skin cancer incidence and prevalence in renal transplant recipients
F.J. Moloney, H. Comber, P. O'Lorcain, P. O'Kelly, P.J. Conlon and G.M. Murphy

A 52-week randomized safety study of a calcipotriol/betamethasone dipropionate two-compound product (Dovobet(R)/Daivobet(R)/Taclonex(R)) in the treatment of psoriasis vulgaris
K. Kragballe, J. Austad, L. Barnes, A. Bibby, M. de la Brassinne, F. Cambazard, C. Fleming, H. Heikkilä, D. Jolliffe, J. Peyri, Å. Svensson, J. Toole and G. Wozel

Clinical experience acquired with the efalizumab (Raptiva(R)) (CLEAR) trial in patients with moderate-to-severe plaque psoriasis: results from a phase III international randomized, placebo-controlled trial
L. Dubertret, W. Sterry, J.D. Bos, S. Chimenti, S. Shumack, C.G. Larsen, N.H. Shear and K.A. Papp

Evidence-based practice of photopheresis 1987-2001: a report of a workshop of the British Photodermatology Group and the U.K. Skin Lymphoma Group
K.E. McKenna, S. Whittaker, L.E. Rhodes, P. Taylor, J. Lloyd, S. Ibbotson and R. Russell-Jones

Etanercept: effective in the management of hidradenitis suppurativa
C. Cusack and C. Buckley